NCT04551521 2025-01-08CRAFT: The NCT-PMO-1602 Phase II TrialGerman Cancer Research CenterPhase 2 Completed72 enrolled
NCT03284502 2023-08-01HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid TumorsHanmi Pharmaceutical Company LimitedPhase 1 Unknown148 enrolled